ResMed Inc.
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionVan Eck Associates Corp
Latest Disclosed Ownership50,790 shares
Latest Disclosed Value $ 11,401
Van Eck Associates Corp reports 0.12% increase in ownership of RMD / ResMed Inc.

On May 15, 2026 - Van Eck Associates Corp filed a 13F-HR form disclosing ownership of 50,790 shares of ResMed Inc. (MX:RMD) valued at $11,401 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 50,730 shares of ResMed Inc.. This represents a change in shares of 0.12% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ResMed COM 761152107 50,790 60 0.12 11 -8.33 0.0075
2026-02-13 2025-12-31 13F ResMed COM 761152107 50,730 2,783 5.80 12 -7.69 0.0101
2025-11-13 2025-09-30 13F ResMed COM 761152107 47,947 -3,941 -7.60 13 0.00 0.0122
2025-08-14 2025-06-30 13F ResMed COM 761152107 51,888 -4,959 -8.72 13 8.33 0.0152
2025-05-15 2025-03-31 13F ResMed COM 761152107 56,847 15,568 37.71 13 33.33 0.0164
2025-01-29 2024-12-31 13F ResMed COM 761152107 41,279 1,945 4.94 9 0.00 0.0121
2024-10-29 2024-09-30 13F ResMed COM 761152107 39,334 1,121 2.93 9 28.57 0.0117
2024-07-31 2024-06-30 13F ResMed COM 761152107 38,213 11,629 43.74 7 40.00 0.0104
2024-04-30 2024-03-31 13F ResMed COM 761152107 26,584 735 2.84 5 25.00 0.0080
2024-02-05 2023-12-31 13F ResMed COM 761152107 25,849 -5,713 -18.10 4 0.00 0.0081
2023-11-08 2023-09-30 13F ResMed COM 761152107 31,562 693 2.24 5 -33.33 0.0102
2023-08-03 2023-06-30 13F ResMed COM 761152107 30,869 3,771 13.92 7 20.00 0.0148
2023-05-03 2023-03-31 13F ResMed COM 761152107 27,098 6,845 33.80 6 25.00 0.0135
2023-02-08 2022-12-31 13F ResMed COM 761152107 20,253 3,019 17.52 4 -99.89 0.0109
2022-10-27 2022-09-30 13F ResMed COM 761152107 17,234 2,114 13.98 3,762 18.68 0.0112
2022-08-03 2022-06-30 13F ResMed COM 761152107 15,120 -209 -1.36 3,170 -14.72 0.0084
2022-05-10 2022-03-31 13F ResMed COM 761152107 15,329 1,502 10.86 3,717 3.19 0.0077
2022-01-26 2021-12-31 13F ResMed COM 761152107 13,827 -481 -3.36 3,602 -4.48 0.0083
2021-11-03 2021-09-30 13F ResMed COM 761152107 14,308 -2,374 -14.23 3,771 -8.29 0.0095
2021-08-10 2021-06-30 13F ResMed COM 761152107 16,682 11 0.07 4,112 27.11 0.0097
2021-05-13 2021-03-31 13F ResMed COM 761152107 16,671 1,919 13.01 3,235 3.16 0.0088
2021-02-09 2020-12-31 13F ResMed COM 761152107 14,752 4,214 39.99 3,136 73.55 0.0091
2020-12-04 2020-09-30 13F/A-1 ResMed COM 761152107 10,538 2,162 25.81 1,807 12.38 0.0058
2020-11-12 2020-09-30 13F ResMed COM 761152107 10,538 2,162 1,807 5,602.3396
2020-08-14 2020-06-30 13F/A-1 ResMed COM 761152107 8,376 1,671 24.92 1,608 62.75 0.0056
2020-08-10 2020-06-30 13F ResMed COM 761152107 8,376 1,671 1,608 5,462.7802
2020-05-12 2020-03-31 13F ResMed COM 761152107 6,705 670 11.10 988 5.67 0.0050
2020-02-13 2019-12-31 13F ResMed COM 761152107 6,035 5,330 756.03 935 884.21 0.0036
2019-11-08 2019-09-30 13F ResMed COM 761152107 705 110 18.49 95 30.14 0.0004
2019-08-07 2019-06-30 13F ResMed COM 761152107 595 595 73 0.0004
2018-08-13 2018-06-30 13F ResMed COM 761152107 0 -98 -100.00 0 -100.00
2018-05-11 2018-03-31 13F ResMed COM 761152107 98 98 10 0.0000
2017-08-11 2017-06-30 13F ResMed COM 761152107 0 -1,945 -100.00 0 -100.00
2017-05-11 2017-03-31 13F ResMed COM 761152107 1,945 136 7.52 140 25.00 0.0006
2017-02-09 2016-12-31 13F ResMed COM 761152107 1,809 -94 -4.94 112 -8.94 0.0006
2016-11-14 2016-09-30 13F ResMed COM 761152107 1,903 516 37.20 123 39.77 0.0006
2016-08-12 2016-06-30 13F ResMed COM 761152107 1,387 330 31.22 88 44.26 0.0005
2016-05-13 2016-03-31 13F ResMed COM 761152107 1,057 165 18.50 61 27.08 0.0004
2016-02-12 2015-12-31 13F ResMed COM 761152107 892 243 37.44 48 45.45 0.0004
2015-11-12 2015-09-30 13F ResMed COM 761152107 649 99 18.00 33 6.45 0.0003
2015-08-12 2015-06-30 13F ResMed COM 761152107 550 109 24.72 31 -3.12 0.0002
2015-05-14 2015-03-31 13F ResMed COM 761152107 441 209 90.09 32 146.15 0.0002
2015-02-13 2014-12-31 13F ResMed COM 761152107 232 232 13 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.